Product Description
Primoxizar( Moxifloxacin 400 mg) is fourth generation Fluroquinolones has in vitro activity against a wide range of Gram-positive and Gram-negative & anaerobic bacteria pathogens.
Indications
Primoxizar tablets are indicated for the treatment of the following bacterial infections in:
- Acute exacerbations of chronic bronchitis .
- Community acquired pneumonia.
- Acute bacterial sinusitis .
- Uncomplicated urinary tract infections.
- Complicated skin and skin structure infections.
- Intro-abdominal infections.
Combination
Moxifloxacin HCL 400 mg.
Properties
Primoxizar(Moxifloxacin) has a bactericidal action results from the inhibition of both type II topoisomerases (DNA gyrase and topoisomerase IV) required for bacterial DNA replication,transcription and repair.
Available Packages
Primoxizar (Moxifloxacin 400 mg) Carton box containing one strip of 5 film coated tablets.
